IDT Publishes High-Performance Method for CRISPR Off-Target Identification

Integrated DNA Technologies (IDT) has published a peer-reviewed study in Nature Communications, establishing a new benchmark for CRISPR off-target nomination. This advanced method aims to help gene editing developers accurately identify and prioritize biologically relevant sites for confirmation and risk assessment, addressing a key challenge in therapeutic genome editing.